152 related articles for article (PubMed ID: 8679270)
21. Use of samarium Sm 153 lexidronam for the treatment of dogs with primary tumors of the skull: 20 cases (1986-2006).
Vancil JM; Henry CJ; Milner RJ; McCoig AM; Lattimer JC; Villamil JA; McCaw DL; Bryan JN
J Am Vet Med Assoc; 2012 Jun; 240(11):1310-5. PubMed ID: 22607597
[TBL] [Abstract][Full Text] [Related]
22. Radionuclides for metastatic bone pain palliation: a need for rational re-evaluation in the new millennium.
Krishnamurthy GT; Krishnamurthy S
J Nucl Med; 2000 Apr; 41(4):688-91. PubMed ID: 10768570
[No Abstract] [Full Text] [Related]
23. High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood stem cell support in unresectable osteosarcoma.
Franzius C; Bielack S; Flege S; Eckardt J; Sciuk J; Jürgens H; Schober O
Nuklearmedizin; 2001 Dec; 40(6):215-20. PubMed ID: 11797510
[TBL] [Abstract][Full Text] [Related]
24. Marrow irradiation with high-dose 153Samarium-EDTMP followed by chemotherapy and hematopoietic stem cell infusion for acute myelogenous leukemia.
Rodriguez V; Anderson PM; Litzow MR; Erlandson L; Trotz BA; Arndt CA; Khan SP; Wiseman GA
Leuk Lymphoma; 2006 Aug; 47(8):1583-92. PubMed ID: 16966270
[TBL] [Abstract][Full Text] [Related]
25. Samarium-153-EDTMP biodistribution and dosimetry estimation.
Eary JF; Collins C; Stabin M; Vernon C; Petersdorf S; Baker M; Hartnett S; Ferency S; Addison SJ; Appelbaum F
J Nucl Med; 1993 Jul; 34(7):1031-6. PubMed ID: 7686217
[TBL] [Abstract][Full Text] [Related]
26. Samarium 153Sm lexidronam.
Lamb HM; Faulds D
Drugs Aging; 1997 Nov; 11(5):413-8; discussion 419. PubMed ID: 9359026
[TBL] [Abstract][Full Text] [Related]
27. Samarium-153 lexidronam for painful bone metastases.
Med Lett Drugs Ther; 1997 Aug; 39(1008):83-4. PubMed ID: 9286284
[No Abstract] [Full Text] [Related]
28. Maxillectomy and targeted radionuclide therapy with 153Sm-EDTMP in a recurrent canine osteosarcoma.
Moe L; Boysen M; Aas M; Lønaas L; Gamlem H; Bruland OS
J Small Anim Pract; 1996 May; 37(5):241-6. PubMed ID: 8736231
[TBL] [Abstract][Full Text] [Related]
29. [The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life].
Jiang CY; Zhu BL; Zhang YJ
Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):118-21. PubMed ID: 7523052
[TBL] [Abstract][Full Text] [Related]
30. A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases.
Turner JH; Claringbold PG; Hetherington EL; Sorby P; Martindale AA
J Clin Oncol; 1989 Dec; 7(12):1926-31. PubMed ID: 2585026
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous tumor curettage and interstitial delivery of samarium-153 coupled with kyphoplasty for treatment of vertebral metastases.
Cardoso ER; Ashamalla H; Weng L; Mokhtar B; Ali S; Macedon M; Guirguis A
J Neurosurg Spine; 2009 Apr; 10(4):336-42. PubMed ID: 19441992
[TBL] [Abstract][Full Text] [Related]
32. Intraorgan biodistribution and dosimetry of 153Sm-ethylenediaminetetramethylene phosphonate in juvenile rabbit tibia: implications for targeted radiotherapy of osteosarcoma.
Essman SC; Lewis MR; Miller WH
J Nucl Med; 2005 Dec; 46(12):2076-82. PubMed ID: 16330573
[TBL] [Abstract][Full Text] [Related]
33. Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases.
Bayouth JE; Macey DJ; Kasi LP; Fossella FV
J Nucl Med; 1994 Jan; 35(1):63-9. PubMed ID: 7505819
[TBL] [Abstract][Full Text] [Related]
34. [Inhibitory effect of samarium-153-labeled ethylenediaminetetramethylene phosphonate (EDTMP) on bone invasion and osteolysis in Walker 256 carcinoma bearing rats].
Shi B; Fu Z; Lei XH
Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):423-6. PubMed ID: 10920873
[TBL] [Abstract][Full Text] [Related]
35. Samarium-153-EDTMP for palliation of ankylosing spondylitis, Paget's disease and rheumatoid arthritis.
Alberts AS; Brighton SW; Kempff P; Louw WK; Beek AV; Kritzinger V; Westerink HP; van Rensburg AJ
J Nucl Med; 1995 Aug; 36(8):1417-20. PubMed ID: 7543145
[TBL] [Abstract][Full Text] [Related]
36. [Effect of 153Sm-EDTMP on hematopoiesis and vital organs of 93 patients with bone tumor].
Deng H; Tan T; Mo T; Zhong S; Kuan A; Hu Y
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Jun; 26(2):155-9. PubMed ID: 7490021
[TBL] [Abstract][Full Text] [Related]
37. Background, reasons and benefits using the vienna protocol for the treatment of painful bone recurrences with 153Samarium-EDTMP.
Sinzinger H; Weiss K; Hiltunen J
Anticancer Res; 2009 Aug; 29(8):3393-5. PubMed ID: 19661362
[TBL] [Abstract][Full Text] [Related]
38. Dose response relationship and multiple dose efficacy and toxicity of samarium-153-EDTMP in metastatic cancer to bone.
Alberts AS; Smit BJ; Louw WK; van Rensburg AJ; van Beek A; Kritzinger V; Nel JS
Radiother Oncol; 1997 May; 43(2):175-9. PubMed ID: 9192964
[TBL] [Abstract][Full Text] [Related]
39. Internal radionuclide therapy of primary osteosarcoma in dogs, using 153Sm-ethylene-diamino-tetramethylene-phosphonate (EDTMP).
Aas M; Moe L; Gamlem H; Skretting A; Ottesen N; Bruland OS
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3148s-3152s. PubMed ID: 10541356
[TBL] [Abstract][Full Text] [Related]
40. A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
Dispenzieri A; Wiseman GA; Lacy MQ; Hayman SR; Kumar SK; Buadi F; Dingli D; Laumann KM; Allred J; Geyer SM; Litzow MR; Gastineau DA; Inwards DJ; Micallef IN; Ansell SM; Porrata L; Elliott MA; Johnston PB; Hogan WJ; Gertz MA
Am J Hematol; 2010 Jun; 85(6):409-13. PubMed ID: 20513117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
